Headline
The latest stories from AHA Today.
The AHA joined #FirstRespondersFirst, the Dr. Lorna Breen Heroes’ Foundation, American Medical Association, American Nurses Foundation and Schwartz Center for Compassionate Healthcare in launching All In: Wellbeing First for Healthcare, a call to action for health care organizations to prioritize…
The Environmental Protection Agency last week presented AHA’s American Society for Health Care Engineering with its 2021 Partner of the Year—Sustained Excellence Award, the program’s highest honor, for its long-term commitment to fighting climate change and protecting public health through energy…
As part of National Minority Health Month (April), AHA shares takeaways from a conversation with the Henry Ford Health System and Islamic Center of America about their collaboration to increase COVID-19 vaccinations in the Muslim community around Detroit.
The Accelerating COVID 19 Therapeutic Interventions and Vaccines (ACTIV) initiative will enroll up to 13,500 adults aged 30 and over in a Phase 3 clinical trial to evaluate whether certain drugs approved for other conditions safely and effectively treat mild-to-moderate COVID-19, the National…
A recent Health Affairs Blog post by physicians “gives an incomplete account of the implications of allowing new and expanded physician-owned hospitals to bill Medicare and Medicaid,” writes Shira Hollander, AHA senior associate director of policy.
Four in 10 transgender women surveyed in seven U.S. cities in 2019-2020 were HIV positive, including nearly two-thirds of African American/Black and one-third of Hispanic/Latina respondents, the Centers for Disease Control and Prevention reported.
The AHA and Black Coalition against COVID April 21 at 7 p.m. ET will host a town hall on enhancing the opportunities for rural health care providers, public health organizations and rural health advocates as they advance COVID-19 prevention guidance, vaccine acceptance and vaccine administration.
The Food and Drug Administration revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.
Health care providers designated as health center “look-alikes” by the federal Health Center Program may apply through May 14 for a portion of $145 million in grants to advance equitable access to COVID-19 vaccination, testing and treatment in underserved and vulnerable populations, the Department…
As health care organizations increasingly use telehealth during the COVID-19 pandemic and beyond, the Healthcare and Public Health Sector Coordinating Council (HSCC) released a report to help health care leaders assess and mitigate associated cybersecurity risks.